Alteryx, Inc.
NYSE:AYX
48.26 (USD) • At close March 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 970 | 855.354 | 536.135 | 495.308 | 417.91 | 253.57 | 131.607 | 85.79 | 53.821 | 37.984 |
| Cost of Revenue
| 131 | 117.784 | 55.753 | 43.839 | 39.151 | 22.8 | 21.803 | 16.026 | 10.521 | 8.533 |
| Gross Profit
| 839 | 737.57 | 480.382 | 451.469 | 378.759 | 230.77 | 109.804 | 69.764 | 43.3 | 29.451 |
| Gross Profit Ratio
| 0.865 | 0.862 | 0.896 | 0.911 | 0.906 | 0.91 | 0.834 | 0.813 | 0.805 | 0.775 |
| Reseach & Development Expenses
| 220 | 221.453 | 132.42 | 101.117 | 69.1 | 43.449 | 29.342 | 17.481 | 11.103 | 7.787 |
| General & Administrative Expenses
| 201 | 231.717 | 149.747 | 101.439 | 79.943 | 48.267 | 32.241 | 17.72 | 10.039 | 17.264 |
| Selling & Marketing Expenses
| 581 | 541.673 | 334.48 | 252.82 | 191.735 | 109.284 | 66.42 | 57.585 | 43.244 | 24.612 |
| SG&A
| 782 | 773.39 | 484.227 | 354.259 | 271.678 | 157.551 | 98.661 | 75.305 | 53.283 | 41.876 |
| Other Expenses
| 39 | -3.526 | -2.058 | 14.382 | 10.434 | 3.042 | -0.205 | -1.028 | -0.186 | -0.081 |
| Operating Expenses
| 1,002 | 994.843 | 616.647 | 455.376 | 340.778 | 201 | 128.003 | 92.786 | 64.386 | 49.663 |
| Operating Income
| -165 | -257.273 | -136.265 | 10.475 | 37.981 | 29.77 | -18.199 | -23.022 | -21.086 | -20.212 |
| Operating Income Ratio
| -0.17 | -0.301 | -0.254 | 0.021 | 0.091 | 0.117 | -0.138 | -0.268 | -0.392 | -0.532 |
| Total Other Income Expenses Net
| -4 | -56.505 | -41.266 | -38.12 | -31.917 | 3.042 | -0.205 | -1.028 | -0.186 | -0.081 |
| Income Before Tax
| -169 | -313.778 | -177.531 | -27.645 | 6.064 | 25.434 | -18.404 | -24.05 | -21.272 | -20.293 |
| Income Before Tax Ratio
| -0.174 | -0.367 | -0.331 | -0.056 | 0.015 | 0.1 | -0.14 | -0.28 | -0.395 | -0.534 |
| Income Tax Expense
| 10 | 4.721 | 2.15 | -3.271 | -21.079 | -2.586 | -0.905 | 0.208 | 0.178 | 0.036 |
| Net Income
| -179 | -318.499 | -179.681 | -24.374 | 27.143 | 28.02 | -17.499 | -24.258 | -21.45 | -20.329 |
| Net Income Ratio
| -0.185 | -0.372 | -0.335 | -0.049 | 0.065 | 0.111 | -0.133 | -0.283 | -0.399 | -0.535 |
| EPS
| -2.52 | -4.65 | -2.67 | -0.37 | 0.43 | 0.43 | -0.33 | -0.5 | -0.46 | -0.43 |
| EPS Diluted
| -2.52 | -4.65 | -2.67 | -0.37 | 0.4 | 0.43 | -0.33 | -0.5 | -0.46 | -0.43 |
| EBITDA
| -165 | -223.455 | -121.943 | 22.576 | 56.707 | 36.648 | -14.242 | -21.345 | -20.327 | -19.867 |
| EBITDA Ratio
| -0.17 | -0.261 | -0.227 | 0.046 | 0.136 | 0.145 | -0.108 | -0.249 | -0.378 | -0.523 |